Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

Nanoparticle-based materials, such as drug delivery vehicles and diagnostic probes, currently under evaluation in oncology clinical trials are largely not tumor selective. To be clinically successful, the next generation of nanoparticle agents should be tumor selective, nontoxic, and exhibit favorab...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Benezra, Miriam, Penate-Medina, Oula, Zanzonico, Pat B., Schaer, David, Ow, Hooisweng, Burns, Andrew, DeStanchina, Elisa, Longo, Valerie, Herz, Erik, Iyer, Srikant, Wolchok, Jedd, Larson, Steven M., Wiesner, Ulrich, Bradbury, Michelle S.
Format: Artigo
Idioma:Inglês
Publicat: American Society for Clinical Investigation 2011
Matèries:
Technical Advance
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3223837/
https://ncbi.nlm.nih.gov/pubmed/21670497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI45600
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars